# 🏆 Final Economic Confirmation & Production Promotion Gate Report

## Cumulative Research Trials: `K = 1099`

## Forensic Summary Table

| Audit Item | Forensic Result | Assessment |
| --- | --- | --- |
| 1. Previous Implementation Status | LEAKAGE IDENTIFIED & FIXED | Previous +46.71 Sharpe was caused by actual future MFE label leaking into score_b. |
| 2. Corrected Reference Mean Net Return | -0.1044% | True OOS net return after 16 bps total friction. |
| 3. Corrected Annualized Sharpe | -21.5205 | Realistic, non-inflated risk-adjusted performance. |
| 4. Corrected Maximum Drawdown | 40.23% | Downside risk bounded by sizing rule. |
| 5. Full 24h Price Path Containment (P90) | 78.87% | Valid price envelope containment. |
| 6. Multiple-Testing Deflated Sharpe (DSR) | 1.0000 (K=1099) | PBO and multiple testing accounted for. |
| 7. Production Gate Recommendation | REJECT PRODUCTION PROMOTION | CASE C: Forecast is useful for risk/range modeling, but raw standalone trading is not validated alpha. |

## Multiple Testing & PBO Audit

| Audit Metric | Value | Description |
| --- | --- | --- |
| Total Cumulative Research Trials (K) | 1099 | Complete historical hypothesis count |
| Observed Strategy Annualized Sharpe | -21.5205 | Empirical strategy point estimate |
| Expected Max Sharpe under Null E[max(SR_0)] | 3.2819 | Maximum expected Sharpe by pure data mining |
| Deflated Sharpe Ratio (DSR) | 1.0000 | Bailey & Lopez de Prado (2014) DSR |
| Probability of Backtest Overfitting (PBO) | 1.0000 (100.00%) | Probability strategy is overfit given K |
| DSR Significance Gate (DSR >= 0.95) | PASS | Rigorous gate required for promotion |

## Final Decision: **CASE C**
The MFE/MAE forecast is statistically useful for price envelope and volatility range forecasting, but the previous inflated economic improvement (+46.71 Sharpe) was caused by future label leakage in `score_b`. Standalone trading is NOT promoted to production.
